Objective
The objectives of this study were to determine the prevalence of insulin
resistance (IR), dyslipidemia and metabolic syndrome (MS) in children
with asthma, aged 10 to 15 years and to determine if these metabolic
abnormalities showed an association with asthma symptom control and lung
function.